Effect of Different Bariatric Surgery Methods on Metabolic Syndrome in Patients With Severe Obesity Publisher Pubmed



Kabir A¹ ; Izadi S^{1, 2} ; Mashayekhi F³ ; Shokraee K¹ ; Rimaz S⁴ ; Ansar H^{1, 5} ; Farsi F¹ ; Pazouki A^{1, 6, 7} Show Affiliations
Source: Updates in Surgery Published:2024

Abstract

Bariatric surgery (BS) has been as a currently developed treatment of choice for metabolic syndrome (MetS). Which, in turn, is well-known as serious public health concern. Therefore, this study assessed the outcomes of different procedures of BS and possible predictors for improving MetS. This single-center retrospective cohort analysis included bariatric candidates between 2009 and 2017. The operational approach was chosen based on the patient’s condition, as well as the patient’s metabolic profile and the surgeon’s experience. All desired information was evaluated at baseline and 6, 12, and 24 months after the operation. Of the 1111 patients included, 918 (82.6%) were female. There was no considerable trend in the improvement of MetS over the follow-up period of each surgery group. After 6 to 24 months of follow-up, waist circumference reduction was significant in all three types of surgery, and sleeve gastrectomy resulted in the best (but not significant) improvement rates after 24 months (P = 0.079). One anastomosis gastric bypass had highest decrease in percentage of excess weight loss than other procedures (P < 0.001). Each year increase in age was associated with a 4% decrease in MetS remission. In addition, the male gender, was correlated with MetS improvement positively (P = 0.049). Each one-unit increase in hemoglobin A1c (HbA1c) reduced the MetS remission rate by 40%. All three methods of BS were similarly effective in MetS. Consider the predictive value of age, gender, and HbA1c before determining the optimum procedure for each patient is recommended. © Italian Society of Surgery (SIC) 2023.